Effects of dietary polyphenols on gene expression in human vascular endothelial cells

Proceedings of the Nutrition Society

Volumn 67, Issue 1, 2008, Pages 42-47

  Nicholson, Sonja K ^a   Tucker, Gregory A ^a   Brameld, John M ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Gene expression; Human umbilical vein endothelial cells; Polyphenols

Indexed keywords

ANTHOCYANIN; CAFFEIC ACID; CHALCONE DERIVATIVE; ENDOTHELIN 1; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; FERULIC ACID; FLAVANOL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVANONOL DERIVATVE; FLAVONE; FLAVONOID; FLAVONOL DERIVATIVE; GALLIC ACID; GENISTEIN; HYDROGEN PEROXIDE; ISOFLAVONE DERIVATIVE; NITRIC OXIDE SYNTHASE; PHLORETIN; PHLORIZIN; POLYPHENOL; QUERCETIN; RESVERATROL; STILBENE DERIVATIVE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR RISK; CELL FUNCTION; CELL GROWTH; CONCENTRATION (PARAMETERS); DIET; DOWN REGULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG STRUCTURE; ENDOTHELIUM CELL; GENE EXPRESSION; GENETIC CODE; HUMAN; MICROARRAY ANALYSIS; OXIDATIVE STRESS; PROTEIN BINDING; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL VEIN; UPREGULATION; VASCULAR ENDOTHELIUM;

CARDIOVASCULAR DISEASES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FLAVONOIDS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; NITRIC OXIDE SYNTHASE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STILBENES; UMBILICAL VEINS;

EID: 38749131263     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665108006009     Document Type: Article

References (40)

1. Allender S, Peto V, Scarborough P, Boxer A & Rayner M (2007) Coronary Heart Disease Statistics. London: BHF.
2. Vander A, Sherman J & Luciano D (1998) Human Physiology: The Mechanisms of Body Function, 7th ed., pp. 444-448. Columbus, OH: McGraw-Hill.
3. Guyton AC & Hall JE (2006) Textbook of Medical Physiology, 9th ed., pp. 252-253. Philadelphia, PA: Elsevier Inc.
4. De Backer G, Ambrosionie E, Borch-Johnsen K et al. (2003) European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 24, 1601-1610.
5. Department of Health (2003) 5 A DAY health benefits. http://www.dh.gov. uk/en/Policyandguidance/Healthandsocialcaretopics/FiveADay/ FiveADaygeneralinformation/DH_4002343
6. Brat P, Georgé S, Bellamy A, Du Chaffaut L, Scalbert A, Mennen L, Arnault N & Amiot MJ (2006) Daily polyphenol intake in France from fruit and vegetables. J Nutr 136, 2368-2373.
7. Hertog MG, Feskens EJ & Kromhout D (1997) Antioxidant flavonols and coronary heart disease risk. Lancet 349, 699.
8. Zhao B, Guo Q & Xin W (2001) Free radical scavenging by green tea polyphenols. In Flavonoids and Other Polyphenols. Methods in Enzymology, vol. 335, pp. 217-231 [L Packer and H Sies, editors]. London: Academic Press.
9. Manach C, Mazur A & Scalbert A (2005) Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol 16, 77-84.
10. Muntwyler J, Hennekens CH, Manson JE, Buring JE & Gaziano JM (2002) Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. Arch Int Med 162, 1472-1476.
11. Heart Protection Study Collaborative Group (2002) MRC/ BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet 360, 23-33.
12. Hakkinen S (2000) Flavonols and phenolic acids in berries. PhD Thesis, Kuopio University, Finland.
13. Dey PM & Harborne JB (editors) (1989) Methods in Plant Biochemistry, vol. 1: Plant Phenolics, p. 3. London: Academic Press.
14. Manach C, Scalbert A, Morand C, Remesy C & Jimenez L (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79, 727-747.
15. Signorelli P & Ghidoni R (2005) Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem 16, 449-466.
16. Yance DR & Sagar SM (2006) Targeting angiogenesis with integrative cancer therapies. Integrative Cancer Therapies 5, 9-29.
17. Shoskes DA, Zeitlin SI, Shahed A & Rajfer J (1999) Quercetin in men with category III chronic prostatitis: a preliminary prospective, double blind, placebo-controlled trial. Urology 54, 960-963.
18. Lee YS (2005) Role of NADPH oxidase-mediated generation of reactive oxygen species in the mechanism of apoptosis induced by phenolic acids in HepG2 human hepatoma cells. Arch Pharm Res 28, 1183-1189.
19. Sudheer A, Muthukumaran S, Kalpana C, Srinivasan M & Menon VP (2007) Protective effect of ferulic acid on nicotine-induced DNA damage and cellular changes in cultured rat peripheral blood lymphocytes: A comparison with N-acetylcysteine. Toxicol In Vitro 21, 576-585.
20. Guo S, Yang S, Taylor C & Sonenshein GE (2005) Green tea polyphenol epigallocatechin-3 gallate (EGCG) affects gene expression of breast cancer cells transformed by the carcinogen 7,12-dimethylbenz[a]anthracene. J Nutr 135, 2978S-2986S.
21. Borska S, Gebarowska E, Wysocka T, Drag-Zalesińska M & Zabel M (2003) Induction of apoptosis by EGCG in selected tumour cell lines in vitro. Folia Histochem Cytobiol 41, 229-232.
22. Tosetti F, Ferrari N, De Flora S & Albini A (2002) Angioprevention: angiogenesis is a common and key target for cancer chemoprevention. FASEB Journal 16, 2-14.
23. Zern TL and Fernandez ML (2005) Cardioprotective effects of dietary polyphenols. J Nutr 135, 2291-2294.
24. Klabunde RE (2005) Cardiovascular Physiology Concepts. Philadelphia, PA: Lippencott, Williams and Wilkins.
25. Vickers J (1995) Endothelial cells and platelet function. PhD Thesis, University of Nottingham.
26. Fox SI (2004) Human Physiology, 9th ed. Maidenhead, Berks.: McGraw-Hill Higher Education.
27. Levick JR (editor) (2004) An Introduction to Cardiovascular Physiology, 4th ed., pp. 131-132. London: Arnold Publishing.
28. Sherwood L (2003) Fundamentals of Physiology; A Human Perspective, 3rd ed. London: Thomson, Brooks, Cole.
29. Ambra R, Rimbach G, de Pascual Teresa S, Fuchs D, Wenzel U, Daniel H & Virgili F (2006) Genistein affects the expression of genes involved in blood pressure regulation and angiogenesis in primary human endothelial cells. Nutr Metab Cardiovasc Dis 16, 35-43.
30. Oak MH, Chataigneau M, Keravis T, Chataigneau T, Beretz A, Andriantsitohaina R, Stoclet JC, Chang SJ & Schini-Kerth VB (2003) Red wine polyphenolic compounds inhibit vascular endothelial growth factor expression in vascular smooth muscle cells by preventing the activation of the p38 mitogen-activated protein kinase pathway. Arterioscler Thromb Vasc Biol 23, 1001-1007.
31. Wallerath T, Li H, Godtel-Ambrust U, Schwarz PM & Forstermann U (2005) A blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase. Nitric Oxide 12, 97-104.
32. Fagan KA, McMurthy IF & Rodman DM (2001) Role of endothelin-1 in lung disease. Respir Res 2, 90-101.
33. Diebolt M, Bucher B & Andriantsitohaina R (2001) Wine polyphenols decrease blood pressure, improve NO vasodilation, and induce gene expression. Hypertension 38, 159-165.
34. Noé V, Peñuelas S, Lamuela-Raventós RM, Permanyer J, Ciudad CJ & Izquierdo-Pulido M (2004) Epicatechin and a Cocoa Polyphenolic Extract Modulate Gene Expression in Human Caco-2 Cells. J Nutr 134, 2509-2516.
35. Iijima K, Yoshizumi M & Ouchi Y (2003) Effects of red wine polyphenols on vascular smooth muscle cells function-molecular mechanisms of the 'French paradox'. Mech Ageing Dev 123, 1033-1039.
36. Walle T, Hsieh F, DeLegge MH, Oatis JE & Walle UK (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32, 1377-1382.
37. Wallerath T, Poleo D, Li H & Forstermann U (2003) Red wine increases the expression of human endothelial nitric oxide synthase: a mechanism that may contribute to its beneficial cardiovascular effects. J Am Coll Cardiol 41, 471-478.
38. Corder R, Douthwaite JA, Lees DM, Khan NQ, Viseu Dos Santos AC, Wood EG & Carrier MJ (2001) Health: Endothelin-1 synthesis reduced by red wine. Nature 414, 863-864.
39. Liu JC, Chen JJ, Chan P, Cheng CF & Cheng TH (2003) Inhibition of cyclic strain-induced endothelin-1 gene expression by resveratrol. Hypertension 42, 1198-1205.
40. Chao HH, Juan SH, Liu JC, Yang HY, Yang E, Cheng TH & Shyu KG (2005) Resveratrol inhibits angiotensin II-induced endothelin-1 gene expression and subsequent proliferation in rat aortic smooth muscle cells. Eur J Pharmacol 515, 1-9.